ENANTA PHARMACEUTICALS INC (ENTA)
$13.60-$0.20 (-1.45%) Today
Scott T. Rottinghaus - OfficerEnanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Tax withholding / forfeiture | 1 | 1,467 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
53 Form 4 filings on record, the earliest from Nov 27, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Yat Sun Or - Officer | Grant or award | Stock Option (right to buy) | 110,000 | $0.00 | - | |
| Scott T. Rottinghaus - Officer | Grant or award | Stock Option (right to buy) | 110,000 | $0.00 | - | |
 Matthew Paul Kowalsky - Officer | Grant or award | Stock Option (right to buy) | 90,000 | $0.00 | - | |
| Tara Lynn Kieffer - Officer | Grant or award | Stock Option (right to buy) | 100,000 | $0.00 | - | |
| Scott T. Rottinghaus - Officer | Tax withholding / forfeiture | Common Stock | 2,217 | $6.99 | $15K | |
| Yat Sun Or - Officer | Open-market sale | Common Stock | 2,591 | $8.06 | $21K | |
| Jay R. Luly - Officer | Open-market sale | Common Stock | 5,142 | $8.06 | $41K | |
| Scott T. Rottinghaus - Officer | Open-market sale | Common Stock | 866 | $8.06 | $7K | |
| Brendan Luu - Officer | Open-market sale | Common Stock | 2,283 | $8.06 | $18K | |
 Paul J. Mellett - Officer | Open-market sale | Common Stock | 2,591 | $8.06 | $21K | |
| Tara Lynn Kieffer - Officer | Open-market sale | Common Stock | 2,283 | $8.06 | $18K | |
| Paul J. Mellett - Officer | Tax withholding / forfeiture | Common Stock | 1,595 | $8.60 | $14K | |
| Yat Sun Or - Officer | Tax withholding / forfeiture | Common Stock | 1,595 | $8.60 | $14K | |
| Tara Lynn Kieffer - Officer | Tax withholding / forfeiture | Common Stock | 753 | $8.60 | $6K | |
| Jay R. Luly - Officer | Tax withholding / forfeiture | Common Stock | 3,829 | $8.60 | $33K | |
| Brendan Luu - Officer | Tax withholding / forfeiture | Common Stock | 753 | $8.60 | $6K | |
| Matthew Paul Kowalsky - Officer | Grant or award | Stock Option (right to buy) | 75,000 | $0.00 | - | |
| Yat Sun Or - Officer | Grant or award | Stock Option (right to buy) | 87,000 | $0.00 | - | |
| Jay R. Luly - Officer | Grant or award | Stock Option (right to buy) | 250,000 | $0.00 | - | |
| Tara Lynn Kieffer - Officer | Grant or award | Stock Option (right to buy) | 81,000 | $0.00 | - | |
| Brendan Luu - Officer | Grant or award | Stock Option (right to buy) | 75,000 | $0.00 | - | |
| Scott T. Rottinghaus - Officer | Grant or award | Stock Option (right to buy) | 87,000 | $0.00 | - | |
| Paul J. Mellett - Officer | Grant or award | Stock Option (right to buy) | 81,000 | $0.00 | - |
This is as far as the anonymous view goes. Create a free account for all 53 ENTA filings on record.
ENANTA PHARMACEUTICALS INC (ENTA) had 1 insider filing in the last 90 days, with the most recent on 2026-08-10. The full record for ENTA runs to 53 Form 4 filings, the earliest from 2024-11-27. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of ENTA were filed in the last 90 days.
No insider sales of ENTA were filed in the last 90 days. 15 sales are on record for this company.
This page tracks ENTA Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add ENTA to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
